Earnings per share: 10 cents, adjusted vs. loss of 22 cents expected.
Revenue: $14.25 billion vs. $14.42 billion expected.
Pfizer recorded fourth-quarter revenue of $14.25 billion, down 41% from the same period a year ago, due to the plunge in sales of its Covid products.
Quelle
www.cnbc.com/2024/01/30/...r-pfe-q4-earnings-report-2023.html
wie wirds bei Biontech aussehen ? mit weniger Covid produkt Absatz ?
Revenue: $14.25 billion vs. $14.42 billion expected.
Pfizer recorded fourth-quarter revenue of $14.25 billion, down 41% from the same period a year ago, due to the plunge in sales of its Covid products.
Quelle
www.cnbc.com/2024/01/30/...r-pfe-q4-earnings-report-2023.html
wie wirds bei Biontech aussehen ? mit weniger Covid produkt Absatz ?